Biocon Limited

Biocon Limited a biopharmaceutical company manufactures pharmaceuticals and medicinal chemical and botanical products. The company operates through Small Molecules Biologics Branded Formulations and Research Services segments. It focuses in the areas of diabetes oncology immunology dermatology ophthalmology neurology rheumatology and inflammatory diseases. The company provides biosimilars comprising recombinant human insulin insulin glargine biosimilar trastuzumab and other biopharmaceuticals; small molecules such as active pharmaceutical ingredients and generic formulations; and branded formulation products under the Insugen Basalog BIOMAb EGFR CANMAb and ALZUMAb brands. It is also involved in the integrated discovery development and manufacturing services for small and large molecules antibody-drug conjugates and oligonucleotides. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru India.